Asia-Pacific Urological Cancer Therapeutics Drugs Market Report 2017

January 2018 | 110 pages | ID: ABEDE2B85BCEN
QYResearch

Abstracts

In this report, the Asia-Pacific Urological Cancer Therapeutics Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (Units), revenue (Million USD), market share and growth rate of Urological Cancer Therapeutics Drugs for these regions, from 2012 to 2022 (forecast), including

• China
• Japan
• South Korea
• Taiwan
• India
• Southeast Asia
• Australia

Asia-Pacific Urological Cancer Therapeutics Drugs market competition by top manufacturers/players, with Urological Cancer Therapeutics Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Novartis
• Pfizer
• Johnson & Johnson
• AstraZeneca
• Astellas
• Bristol-Myers Squibb
• Abbott Laboratories
• Celgene Corporation
• Dendreon Corporation
• Ferring Pharmaceuticals
• GlaxoSmithKline plc
• Indevus Pharmaceuticals Inc
• Ipsen
• Roche Healthcare
• Sanofi S.A.

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into

• Xofigo (radium Ra 223 dichloride)
• Jevtana (cabazitaxel)
• Inlyta (axitinib)
• Votrient (pazopanib hydrochloride)
• Sutent (sunitinib malate)
• Zytiga (abiraterone acetate)
• Xtandi (enzalutamide)
• Opdivo (nivolumab)
• Provenge (sipuleucel-T)

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Medical Research Laboratory
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Asia-Pacific Urological Cancer Therapeutics Drugs Market Report 2017

1 UROLOGICAL CANCER THERAPEUTICS DRUGS OVERVIEW

1.1 Product Overview and Scope of Urological Cancer Therapeutics Drugs
1.2 Classification of Urological Cancer Therapeutics Drugs by Product Category
  1.2.1 Asia-Pacific Urological Cancer Therapeutics Drugs Market Size (Sales) Comparison by Types (2012-2022)
  1.2.2 Asia-Pacific Urological Cancer Therapeutics Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Xofigo (radium Ra 223 dichloride)
  1.2.4 Jevtana (cabazitaxel)
  1.2.5 Inlyta (axitinib)
  1.2.6 Votrient (pazopanib hydrochloride)
  1.2.7 Sutent (sunitinib malate)
  1.2.8 Zytiga (abiraterone acetate)
  1.2.9 Xtandi (enzalutamide)
  1.2.10 Opdivo (nivolumab)
  1.2.11 Provenge (sipuleucel-T)
1.3 Asia-Pacific Urological Cancer Therapeutics Drugs Market by Application/End Users
  1.3.1 Asia-Pacific Urological Cancer Therapeutics Drugs Sales (Volume) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Hospital
  1.3.3 Medical Research Laboratory
  1.3.4 Others
1.4 Asia-Pacific Urological Cancer Therapeutics Drugs Market by Region
  1.4.1 Asia-Pacific Urological Cancer Therapeutics Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Japan Status and Prospect (2012-2022)
  1.4.4 South Korea Status and Prospect (2012-2022)
  1.4.5 Taiwan Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
  1.4.7 Southeast Asia Status and Prospect (2012-2022)
  1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Urological Cancer Therapeutics Drugs (2012-2022)
  1.5.1 Asia-Pacific Urological Cancer Therapeutics Drugs Sales and Growth Rate (2012-2022)
  1.5.2 Asia-Pacific Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2012-2022)

2 ASIA-PACIFIC UROLOGICAL CANCER THERAPEUTICS DRUGS COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Urological Cancer Therapeutics Drugs Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Urological Cancer Therapeutics Drugs Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Asia-Pacific Urological Cancer Therapeutics Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Urological Cancer Therapeutics Drugs (Volume and Value) by Type
  2.2.1 Asia-Pacific Urological Cancer Therapeutics Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 Asia-Pacific Urological Cancer Therapeutics Drugs Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Urological Cancer Therapeutics Drugs (Volume) by Application
2.4 Asia-Pacific Urological Cancer Therapeutics Drugs (Volume and Value) by Region
  2.4.1 Asia-Pacific Urological Cancer Therapeutics Drugs Sales and Market Share by Region (2012-2017)
  2.4.2 Asia-Pacific Urological Cancer Therapeutics Drugs Revenue and Market Share by Region (2012-2017)

3 CHINA UROLOGICAL CANCER THERAPEUTICS DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 China Urological Cancer Therapeutics Drugs Sales and Value (2012-2017)
  3.1.1 China Urological Cancer Therapeutics Drugs Sales Volume and Growth Rate (2012-2017)
  3.1.2 China Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2012-2017)
  3.1.3 China Urological Cancer Therapeutics Drugs Sales Price Trend (2012-2017)
3.2 China Urological Cancer Therapeutics Drugs Sales Volume and Market Share by Type
3.3 China Urological Cancer Therapeutics Drugs Sales Volume and Market Share by Application

4 JAPAN UROLOGICAL CANCER THERAPEUTICS DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Urological Cancer Therapeutics Drugs Sales and Value (2012-2017)
  4.1.1 Japan Urological Cancer Therapeutics Drugs Sales Volume and Growth Rate (2012-2017)
  4.1.2 Japan Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2012-2017)
  4.1.3 Japan Urological Cancer Therapeutics Drugs Sales Price Trend (2012-2017)
4.2 Japan Urological Cancer Therapeutics Drugs Sales Volume and Market Share by Type
4.3 Japan Urological Cancer Therapeutics Drugs Sales Volume and Market Share by Application

5 SOUTH KOREA UROLOGICAL CANCER THERAPEUTICS DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Urological Cancer Therapeutics Drugs Sales and Value (2012-2017)
  5.1.1 South Korea Urological Cancer Therapeutics Drugs Sales Volume and Growth Rate (2012-2017)
  5.1.2 South Korea Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2012-2017)
  5.1.3 South Korea Urological Cancer Therapeutics Drugs Sales Price Trend (2012-2017)
5.2 South Korea Urological Cancer Therapeutics Drugs Sales Volume and Market Share by Type
5.3 South Korea Urological Cancer Therapeutics Drugs Sales Volume and Market Share by Application

6 TAIWAN UROLOGICAL CANCER THERAPEUTICS DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Urological Cancer Therapeutics Drugs Sales and Value (2012-2017)
  6.1.1 Taiwan Urological Cancer Therapeutics Drugs Sales Volume and Growth Rate (2012-2017)
  6.1.2 Taiwan Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2012-2017)
  6.1.3 Taiwan Urological Cancer Therapeutics Drugs Sales Price Trend (2012-2017)
6.2 Taiwan Urological Cancer Therapeutics Drugs Sales Volume and Market Share by Type
6.3 Taiwan Urological Cancer Therapeutics Drugs Sales Volume and Market Share by Application

7 INDIA UROLOGICAL CANCER THERAPEUTICS DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 India Urological Cancer Therapeutics Drugs Sales and Value (2012-2017)
  7.1.1 India Urological Cancer Therapeutics Drugs Sales Volume and Growth Rate (2012-2017)
  7.1.2 India Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2012-2017)
  7.1.3 India Urological Cancer Therapeutics Drugs Sales Price Trend (2012-2017)
7.2 India Urological Cancer Therapeutics Drugs Sales Volume and Market Share by Type
7.3 India Urological Cancer Therapeutics Drugs Sales Volume and Market Share by Application

8 SOUTHEAST ASIA UROLOGICAL CANCER THERAPEUTICS DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Urological Cancer Therapeutics Drugs Sales and Value (2012-2017)
  8.1.1 Southeast Asia Urological Cancer Therapeutics Drugs Sales Volume and Growth Rate (2012-2017)
  8.1.2 Southeast Asia Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2012-2017)
  8.1.3 Southeast Asia Urological Cancer Therapeutics Drugs Sales Price Trend (2012-2017)
8.2 Southeast Asia Urological Cancer Therapeutics Drugs Sales Volume and Market Share by Type
8.3 Southeast Asia Urological Cancer Therapeutics Drugs Sales Volume and Market Share by Application

9 AUSTRALIA UROLOGICAL CANCER THERAPEUTICS DRUGS (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Urological Cancer Therapeutics Drugs Sales and Value (2012-2017)
  9.1.1 Australia Urological Cancer Therapeutics Drugs Sales Volume and Growth Rate (2012-2017)
  9.1.2 Australia Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2012-2017)
  9.1.3 Australia Urological Cancer Therapeutics Drugs Sales Price Trend (2012-2017)
9.2 Australia Urological Cancer Therapeutics Drugs Sales Volume and Market Share by Type
9.3 Australia Urological Cancer Therapeutics Drugs Sales Volume and Market Share by Application

10 ASIA-PACIFIC UROLOGICAL CANCER THERAPEUTICS DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Novartis
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Urological Cancer Therapeutics Drugs Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Novartis Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 Pfizer
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Urological Cancer Therapeutics Drugs Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Pfizer Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 Johnson & Johnson
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Urological Cancer Therapeutics Drugs Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Johnson & Johnson Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 AstraZeneca
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Urological Cancer Therapeutics Drugs Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 AstraZeneca Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 Astellas
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Urological Cancer Therapeutics Drugs Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Astellas Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 Bristol-Myers Squibb
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Urological Cancer Therapeutics Drugs Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 Abbott Laboratories
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Urological Cancer Therapeutics Drugs Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Abbott Laboratories Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview
10.8 Celgene Corporation
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Urological Cancer Therapeutics Drugs Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Celgene Corporation Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Main Business/Business Overview
10.9 Dendreon Corporation
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Urological Cancer Therapeutics Drugs Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Dendreon Corporation Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Main Business/Business Overview
10.10 Ferring Pharmaceuticals
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Urological Cancer Therapeutics Drugs Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.10.4 Main Business/Business Overview
10.11 GlaxoSmithKline plc
10.12 Indevus Pharmaceuticals Inc
10.13 Ipsen
10.14 Roche Healthcare
10.15 Sanofi S.A.

11 UROLOGICAL CANCER THERAPEUTICS DRUGS MANUFACTURING COST ANALYSIS

11.1 Urological Cancer Therapeutics Drugs Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Urological Cancer Therapeutics Drugs

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Urological Cancer Therapeutics Drugs Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Urological Cancer Therapeutics Drugs Major Manufacturers in 2016
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC UROLOGICAL CANCER THERAPEUTICS DRUGS MARKET FORECAST (2017-2022)

15.1 Asia-Pacific Urological Cancer Therapeutics Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
  15.1.1 Asia-Pacific Urological Cancer Therapeutics Drugs Sales Volume and Growth Rate Forecast (2017-2022)
  15.1.2 Asia-Pacific Urological Cancer Therapeutics Drugs Revenue and Growth Rate Forecast (2017-2022)
  15.1.3 Asia-Pacific Urological Cancer Therapeutics Drugs Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Urological Cancer Therapeutics Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.1 Asia-Pacific Urological Cancer Therapeutics Drugs Sales Volume and Growth Rate Forecast by Region (2017-2022)
  15.2.2 Asia-Pacific Urological Cancer Therapeutics Drugs Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.3 China Urological Cancer Therapeutics Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.4 Japan Urological Cancer Therapeutics Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.5 South Korea Urological Cancer Therapeutics Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.6 Taiwan Urological Cancer Therapeutics Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.7 India Urological Cancer Therapeutics Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.8 Southeast Asia Urological Cancer Therapeutics Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.9 Australia Urological Cancer Therapeutics Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Urological Cancer Therapeutics Drugs Sales, Revenue and Price Forecast by Type (2017-2022)
  15.3.1 Asia-Pacific Urological Cancer Therapeutics Drugs Sales Forecast by Type (2017-2022)
  15.3.2 Asia-Pacific Urological Cancer Therapeutics Drugs Revenue Forecast by Type (2017-2022)
  15.3.3 Asia-Pacific Urological Cancer Therapeutics Drugs Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Urological Cancer Therapeutics Drugs Sales Forecast by Application (2017-2022)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Urological Cancer Therapeutics Drugs
Figure Asia-Pacific Urological Cancer Therapeutics Drugs Sales Volume (Units) by Type (2012-2022)
Figure Asia-Pacific Urological Cancer Therapeutics Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Xofigo (radium Ra 223 dichloride) Product Picture
Figure Jevtana (cabazitaxel) Product Picture
Figure Inlyta (axitinib) Product Picture
Figure Votrient (pazopanib hydrochloride) Product Picture
Figure Sutent (sunitinib malate) Product Picture
Figure Zytiga (abiraterone acetate) Product Picture
Figure Xtandi (enzalutamide) Product Picture
Figure Opdivo (nivolumab) Product Picture
Figure Provenge (sipuleucel-T) Product Picture
Figure Asia-Pacific Urological Cancer Therapeutics Drugs Sales (Units) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Urological Cancer Therapeutics Drugs by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Medical Research Laboratory Examples
Table Key Downstream Customer in Medical Research Laboratory
Figure Others Examples
Table Key Downstream Customer in Others
Figure Asia-Pacific Urological Cancer Therapeutics Drugs Market Size (Million USD) by Region (2012-2022)
Figure China Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Urological Cancer Therapeutics Drugs Sales Volume (Units) and Growth Rate (2012-2022)
Figure Asia-Pacific Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Urological Cancer Therapeutics Drugs Market Major Players Product Sales Volume (Units)(2012-2017)
Table Asia-Pacific Urological Cancer Therapeutics Drugs Sales (Units) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Urological Cancer Therapeutics Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Urological Cancer Therapeutics Drugs Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Urological Cancer Therapeutics Drugs Sales Share by Players/Suppliers
Figure Asia-Pacific Urological Cancer Therapeutics Drugs Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Urological Cancer Therapeutics Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Urological Cancer Therapeutics Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Urological Cancer Therapeutics Drugs Revenue Share by Players
Figure 2017 Asia-Pacific Urological Cancer Therapeutics Drugs Revenue Share by Players
Table Asia-Pacific Urological Cancer Therapeutics Drugs Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Urological Cancer Therapeutics Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Urological Cancer Therapeutics Drugs by Type (2012-2017)
Figure Asia-Pacific Urological Cancer Therapeutics Drugs Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Urological Cancer Therapeutics Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Urological Cancer Therapeutics Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Urological Cancer Therapeutics Drugs by Type (2012-2017)
Figure Asia-Pacific Urological Cancer Therapeutics Drugs Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Urological Cancer Therapeutics Drugs Sales Volume (Units) and Market Share by Region (2012-2017)
Table Asia-Pacific Urological Cancer Therapeutics Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Urological Cancer Therapeutics Drugs by Region (2012-2017)
Figure Asia-Pacific Urological Cancer Therapeutics Drugs Sales Market Share by Region in 2016
Table Asia-Pacific Urological Cancer Therapeutics Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Urological Cancer Therapeutics Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Urological Cancer Therapeutics Drugs by Region (2012-2017)
Figure Asia-Pacific Urological Cancer Therapeutics Drugs Revenue Market Share by Region in 2016
Table Asia-Pacific Urological Cancer Therapeutics Drugs Sales Volume (Units) and Market Share by Application (2012-2017)
Table Asia-Pacific Urological Cancer Therapeutics Drugs Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Urological Cancer Therapeutics Drugs Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Urological Cancer Therapeutics Drugs Sales Market Share by Application (2012-2017)
Figure China Urological Cancer Therapeutics Drugs Sales (Units) and Growth Rate (2012-2017)
Figure China Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Urological Cancer Therapeutics Drugs Sales Price (K USD/Unit) Trend (2012-2017)
Table China Urological Cancer Therapeutics Drugs Sales Volume (Units) by Type (2012-2017)
Table China Urological Cancer Therapeutics Drugs Sales Volume Market Share by Type (2012-2017)
Figure China Urological Cancer Therapeutics Drugs Sales Volume Market Share by Type in 2016
Table China Urological Cancer Therapeutics Drugs Sales Volume (Units) by Applications (2012-2017)
Table China Urological Cancer Therapeutics Drugs Sales Volume Market Share by Application (2012-2017)
Figure China Urological Cancer Therapeutics Drugs Sales Volume Market Share by Application in 2016
Figure Japan Urological Cancer Therapeutics Drugs Sales (Units) and Growth Rate (2012-2017)
Figure Japan Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Urological Cancer Therapeutics Drugs Sales Price (K USD/Unit) Trend (2012-2017)
Table Japan Urological Cancer Therapeutics Drugs Sales Volume (Units) by Type (2012-2017)
Table Japan Urological Cancer Therapeutics Drugs Sales Volume Market Share by Type (2012-2017)
Figure Japan Urological Cancer Therapeutics Drugs Sales Volume Market Share by Type in 2016
Table Japan Urological Cancer Therapeutics Drugs Sales Volume (Units) by Applications (2012-2017)
Table Japan Urological Cancer Therapeutics Drugs Sales Volume Market Share by Application (2012-2017)
Figure Japan Urological Cancer Therapeutics Drugs Sales Volume Market Share by Application in 2016
Figure South Korea Urological Cancer Therapeutics Drugs Sales (Units) and Growth Rate (2012-2017)
Figure South Korea Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Urological Cancer Therapeutics Drugs Sales Price (K USD/Unit) Trend (2012-2017)
Table South Korea Urological Cancer Therapeutics Drugs Sales Volume (Units) by Type (2012-2017)
Table South Korea Urological Cancer Therapeutics Drugs Sales Volume Market Share by Type (2012-2017)
Figure South Korea Urological Cancer Therapeutics Drugs Sales Volume Market Share by Type in 2016
Table South Korea Urological Cancer Therapeutics Drugs Sales Volume (Units) by Applications (2012-2017)
Table South Korea Urological Cancer Therapeutics Drugs Sales Volume Market Share by Application (2012-2017)
Figure South Korea Urological Cancer Therapeutics Drugs Sales Volume Market Share by Application in 2016
Figure Taiwan Urological Cancer Therapeutics Drugs Sales (Units) and Growth Rate (2012-2017)
Figure Taiwan Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Urological Cancer Therapeutics Drugs Sales Price (K USD/Unit) Trend (2012-2017)
Table Taiwan Urological Cancer Therapeutics Drugs Sales Volume (Units) by Type (2012-2017)
Table Taiwan Urological Cancer Therapeutics Drugs Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Urological Cancer Therapeutics Drugs Sales Volume Market Share by Type in 2016
Table Taiwan Urological Cancer Therapeutics Drugs Sales Volume (Units) by Applications (2012-2017)
Table Taiwan Urological Cancer Therapeutics Drugs Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Urological Cancer Therapeutics Drugs Sales Volume Market Share by Application in 2016
Figure India Urological Cancer Therapeutics Drugs Sales (Units) and Growth Rate (2012-2017)
Figure India Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Urological Cancer Therapeutics Drugs Sales Price (K USD/Unit) Trend (2012-2017)
Table India Urological Cancer Therapeutics Drugs Sales Volume (Units) by Type (2012-2017)
Table India Urological Cancer Therapeutics Drugs Sales Volume Market Share by Type (2012-2017)
Figure India Urological Cancer Therapeutics Drugs Sales Volume Market Share by Type in 2016
Table India Urological Cancer Therapeutics Drugs Sales Volume (Units) by Application (2012-2017)
Table India Urological Cancer Therapeutics Drugs Sales Volume Market Share by Application (2012-2017)
Figure India Urological Cancer Therapeutics Drugs Sales Volume Market Share by Application in 2016
Figure Southeast Asia Urological Cancer Therapeutics Drugs Sales (Units) and Growth Rate (2012-2017)
Figure Southeast Asia Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Urological Cancer Therapeutics Drugs Sales Price (K USD/Unit) Trend (2012-2017)
Table Southeast Asia Urological Cancer Therapeutics Drugs Sales Volume (Units) by Type (2012-2017)
Table Southeast Asia Urological Cancer Therapeutics Drugs Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Urological Cancer Therapeutics Drugs Sales Volume Market Share by Type in 2016
Table Southeast Asia Urological Cancer Therapeutics Drugs Sales Volume (Units) by Applications (2012-2017)
Table Southeast Asia Urological Cancer Therapeutics Drugs Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Urological Cancer Therapeutics Drugs Sales Volume Market Share by Application in 2016
Figure Australia Urological Cancer Therapeutics Drugs Sales (Units) and Growth Rate (2012-2017)
Figure Australia Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Urological Cancer Therapeutics Drugs Sales Price (K USD/Unit) Trend (2012-2017)
Table Australia Urological Cancer Therapeutics Drugs Sales Volume (Units) by Type (2012-2017)
Table Australia Urological Cancer Therapeutics Drugs Sales Volume Market Share by Type (2012-2017)
Figure Australia Urological Cancer Therapeutics Drugs Sales Volume Market Share by Type in 2016
Table Australia Urological Cancer Therapeutics Drugs Sales Volume (Units) by Applications (2012-2017)
Table Australia Urological Cancer Therapeutics Drugs Sales Volume Market Share by Application (2012-2017)
Figure Australia Urological Cancer Therapeutics Drugs Sales Volume Market Share by Application in 2016
Table Novartis Urological Cancer Therapeutics Drugs Basic Information List
Table Novartis Urological Cancer Therapeutics Drugs Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Urological Cancer Therapeutics Drugs Sales (Units) and Growth Rate (2012-2017)
Figure Novartis Urological Cancer Therapeutics Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Novartis Urological Cancer Therapeutics Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Pfizer Urological Cancer Therapeutics Drugs Basic Information List
Table Pfizer Urological Cancer Therapeutics Drugs Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Urological Cancer Therapeutics Drugs Sales (Units) and Growth Rate (2012-2017)
Figure Pfizer Urological Cancer Therapeutics Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Pfizer Urological Cancer Therapeutics Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Johnson & Johnson Urological Cancer Therapeutics Drugs Basic Information List
Table Johnson & Johnson Urological Cancer Therapeutics Drugs Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Urological Cancer Therapeutics Drugs Sales (Units) and Growth Rate (2012-2017)
Figure Johnson & Johnson Urological Cancer Therapeutics Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Johnson & Johnson Urological Cancer Therapeutics Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table AstraZeneca Urological Cancer Therapeutics Drugs Basic Information List
Table AstraZeneca Urological Cancer Therapeutics Drugs Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Urological Cancer Therapeutics Drugs Sales (Units) and Growth Rate (2012-2017)
Figure AstraZeneca Urological Cancer Therapeutics Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure AstraZeneca Urological Cancer Therapeutics Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Astellas Urological Cancer Therapeutics Drugs Basic Information List
Table Astellas Urological Cancer Therapeutics Drugs Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Astellas Urological Cancer Therapeutics Drugs Sales (Units) and Growth Rate (2012-2017)
Figure Astellas Urological Cancer Therapeutics Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Astellas Urological Cancer Therapeutics Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Basic Information List
Table Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Sales (Units) and Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Abbott Laboratories Urological Cancer Therapeutics Drugs Basic Information List
Table Abbott Laboratories Urological Cancer Therapeutics Drugs Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Laboratories Urological Cancer Therapeutics Drugs Sales (Units) and Growth Rate (2012-2017)
Figure Abbott Laboratories Urological Cancer Therapeutics Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Abbott Laboratories Urological Cancer Therapeutics Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Celgene Corporation Urological Cancer Therapeutics Drugs Basic Information List
Table Celgene Corporation Urological Cancer Therapeutics Drugs Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Celgene Corporation Urological Cancer Therapeutics Drugs Sales (Units) and Growth Rate (2012-2017)
Figure Celgene Corporation Urological Cancer Therapeutics Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Celgene Corporation Urological Cancer Therapeutics Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Dendreon Corporation Urological Cancer Therapeutics Drugs Basic Information List
Table Dendreon Corporation Urological Cancer Therapeutics Drugs Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Dendreon Corporation Urological Cancer Therapeutics Drugs Sales (Units) and Growth Rate (2012-2017)
Figure Dendreon Corporation Urological Cancer Therapeutics Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Dendreon Corporation Urological Cancer Therapeutics Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Basic Information List
Table Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Sales (Units) and Growth Rate (2012-2017)
Figure Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table GlaxoSmithKline plc Urological Cancer Therapeutics Drugs Basic Information List
Table Indevus Pharmaceuticals Inc Urological Cancer Therapeutics Drugs Basic Information List
Table Ipsen Urological Cancer Therapeutics Drugs Basic Information List
Table Roche Healthcare Urological Cancer Therapeutics Drugs Basic Information List
Table Sanofi S.A. Urological Cancer Therapeutics Drugs Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (K USD/Unit) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Urological Cancer Therapeutics Drugs
Figure Manufacturing Process Analysis of Urological Cancer Therapeutics Drugs
Figure Urological Cancer Therapeutics Drugs Industrial Chain Analysis
Table Raw Materials Sources of Urological Cancer Therapeutics Drugs Major Manufacturers in 2016
Table Major Buyers of Urological Cancer Therapeutics Drugs
Table Distributors/Traders List
Figure Asia-Pacific Urological Cancer Therapeutics Drugs Sales Volume (Units) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Urological Cancer Therapeutics Drugs Price (K USD/Unit) and Trend Forecast (2017-2022)
Table Asia-Pacific Urological Cancer Therapeutics Drugs Sales Volume (Units) Forecast by Region (2017-2022)
Figure Asia-Pacific Urological Cancer Therapeutics Drugs Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Urological Cancer Therapeutics Drugs Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Urological Cancer Therapeutics Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Urological Cancer Therapeutics Drugs Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Urological Cancer Therapeutics Drugs Revenue Market Share Forecast by Region in 2022
Figure China Urological Cancer Therapeutics Drugs Sales (Units) and Growth Rate Forecast (2017-2022)
Figure China Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Urological Cancer Therapeutics Drugs Sales (Units) and Growth Rate Forecast (2017-2022)
Figure Japan Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Urological Cancer Therapeutics Drugs Sales (Units) and Growth Rate Forecast (2017-2022)
Figure South Korea Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Urological Cancer Therapeutics Drugs Sales (Units) and Growth Rate Forecast (2017-2022)
Figure Taiwan Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Urological Cancer Therapeutics Drugs Sales (Units) and Growth Rate Forecast (2017-2022)
Figure India Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Urological Cancer Therapeutics Drugs Sales (Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Urological Cancer Therapeutics Drugs Sales (Units) and Growth Rate Forecast (2017-2022)
Figure Australia Urological Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Urological Cancer Therapeutics Drugs Sales (Units) Forecast by Type (2017-2022)
Figure Asia-Pacific Urological Cancer Therapeutics Drugs Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Urological Cancer Therapeutics Drugs Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Urological Cancer Therapeutics Drugs Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Urological Cancer Therapeutics Drugs Price (K USD/Unit) Forecast by Type (2017-2022)
Table Asia-Pacific Urological Cancer Therapeutics Drugs Sales (Units) Forecast by Application (2017-2022)
Figure Asia-Pacific Urological Cancer Therapeutics Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources